Back to search

Article

Mutation-driven evolution of <i>Pseudomonas aeruginosa</i> in the presence of either ceftazidime or ceftazidime/avibactam

2018-06-30

Abstract excerpt

<h4>ABSTRACT</h4> Ceftazidime/avibactam is a combination of beta-lactam/beta-lactamases inhibitor, which use is restricted to some clinical cases including cystic fibrosis patients infected with multidrug resistant Pseudomonas aeruginosa , in which mutation is the main driver of resistance. This study aims to predict the mechanisms of mutation-driven resistance that are selected for when P. aeruginosa is challe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b4db6d5-7f26-57bd-b9b6-fb6b1a1bd665
DOI
10.1101/359802
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutation-driven evolution of <i>Pseudomonas aeruginosa</i> in the presence of either ceftazidime or ceftazidime/avibactamDOI 10.1101/359802
Select a neighboring publication to make it the new centre.